ArticleOncotarget2018

Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect.

Joo-Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.